Edition:
United Kingdom

Julie Steenhuysen

Eisai, Biogen Alzheimer's data fails to convince skeptics

25 Oct 2018

Eisai Co Ltd and partner Biogen Inc said on Thursday that the highest dose of their experimental Alzheimer's disease drug showed effectiveness in a new analysis, but investors remained skeptical about the reliability of the data and Biogen shares fell about 2 percent.

UPDATE 1-Biogen shares slip after Alzheimer's data fails to convince

25 Oct 2018

Oct 25 Biogen Inc and partner Eisai Co Ltd said on Thursday the highest dose of its experimental Alzheimer's drug showed effectiveness in a new analysis, but investors remained skeptical about the reliability of the data.

RPT-EXPLAINER-Why it’s so hard to diagnose Zika

17 Oct 2018

CHICAGO, Oct 17 When a Zika epidemic was at its height in the Americas two years ago, diagnostics makers began working feverishly to create diagnostic tests for a virus that few in the U.S. had heard of.

RPT-INSIGHT-Zika in Africa: Rare birth defect on the rise in Angola

17 Oct 2018

LUANDA/CHICAGO, Oct 17 Emiliano Cula starts to cry as his tiny fingers, curled into a tight fist, are stretched by a physical therapist to stimulate motor control.

Why it’s so hard to diagnose Zika

17 Oct 2018

CHICAGO When a Zika epidemic was at its height in the Americas two years ago, diagnostics makers began working feverishly to create diagnostic tests for a virus that few in the U.S. had heard of.

Zika in Africa - Rare birth defect on the rise in Angola

17 Oct 2018

LUANDA/CHICAGO Emiliano Cula starts to cry as his tiny fingers, curled into a tight fist, are stretched by a physical therapist to stimulate motor control.

Why it's so hard to diagnose Zika

17 Oct 2018

CHICAGO When a Zika epidemic was at its height in the Americas two years ago, diagnostics makers began working feverishly to create diagnostic tests for a virus that few in the U.S. had heard of.

Explainer: Why it’s so hard to diagnose Zika

17 Oct 2018

CHICAGO When a Zika epidemic was at its height in the Americas two years ago, diagnostics makers began working feverishly to create diagnostic tests for a virus that few in the U.S. had heard of.

EXPLAINER-Why it’s so hard to diagnose Zika

17 Oct 2018

CHICAGO, Oct 17 When a Zika epidemic was at its height in the Americas two years ago, diagnostics makers began working feverishly to create diagnostic tests for a virus that few in the U.S. had heard of.

Rare manufacturing glitch raises concern over CAR-T therapies: study

01 Oct 2018

CHICAGO A single leukemia cell inadvertently got mixed in with a batch of a patient's immune cells that were being manufactured into a CAR-T cell therapy and it acquired resistance to the treatment with deadly results, University of Pennsylvania researchers reported on Monday.

World News